Zeposia
Payments companies reported to CMS as associated with Zeposia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zeposia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zeposia
These are the largest totals companies reported as associated with Zeposia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| George Salem | Oklahoma City, OK | Gastroenterology (Internal Medicine) | $143,205.08 |
| Shadi Hamdeh | Kansas City, KS | Internal Medicine | $139,183.20 |
| Stephen Hanauer | Chicago, IL | Gastroenterology (Internal Medicine) | $129,629.84 |
| Caterina Oneto Araya | New York, NY | Gastroenterology (Internal Medicine) | $110,793.09 |
| Bruce Hughes | Des Moines, IA | Neurology (Psychiatry & Neurology) | $105,604.40 |
| Douglas Nguyen | Mission Viejo, CA | Gastroenterology (Internal Medicine) | $103,369.27 |
| Arthur Kornbluth | New York, NY | Gastroenterology (Internal Medicine) | $101,749.75 |
| Christian Stone | Las Vegas, NV | Gastroenterology (Internal Medicine) | $95,279.80 |
| Barry Hendin | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $83,202.45 |
| Steven Bromley | Audubon, NJ | Neurology (Psychiatry & Neurology) | $79,314.03 |
Prescribed Zeposia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.